Berg Media

April 4, 2018

BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

Press releases

March 19, 2018

How Big Pharma is Using AI to Make Better Drugs

News

March 19, 2018

Chief Analytics Officer Slava Akmaev to Speak at BioData World

Events

February 25, 2018

Assoc. Dir. of Advanced Analytics Leo Rodrigues to Discuss Industrialization of AI

Events

February 16, 2018

Assoc. Dir. of Advanced Analytics Leo Rodrigues to Speak at AI in Pharma Summit

Events

February 12, 2018

Chief Analytics Officer Slava Akmaev to Speak at SCOPE

Events

January 25, 2018

AI is Helping Turn Tide Against Flu in Two Important Ways

News

January 22, 2018

BERG Announces FDA Orphan-Drug Designation of BPM31510 for the Treatment of Pancreatic Cancer

Press releases

January 19, 2018

Flu Epidemic Could Cost Employers $9 Billion

News

January 16, 2018

Flu-pocalypse? Why Scientists are Scrambling to Make ‘Universal Influenza Vaccine’

News

January 3, 2018

Chief Analytics Officer Slava Akmaev to Speak at Precision Medicine World Conference

Events

December 15, 2017

BERG Teams with Mass General Hospital, Brigham and Women’s Hospital to Combat Alzheimer’s Disease

News

December 13, 2017

New Research Partnership will Leverage BERG’s Interrogative Biology® Platform to Identify Novel Biomarker and Targets for Diagnosis and Treatment of Alzheimer’s Disease

Press releases

December 6, 2017

Chief Analytics Officer Slava Akmaev to Speak at AI Applications Summit

Events

November 20, 2017

BERG, AstraZeneca Partnership Highlighted in Forbes Column

News

November 8, 2017

BERG Helps Establish McLeod Research Fellowship at USUHS

News

November 8, 2017

BERG at Neuroscience 2017 Conference

Events

November 1, 2017

CEO Niven Narain Discusses Partnership with Sanofi Pasteur

News

October 31, 2017

BERG, Sanofi team up on AI-flu vaccine project

News

October 31, 2017

Sanofi turns to artificial intelligence to beat flu

News

October 30, 2017

BERG Enters Into an Agreement With Sanofi Pasteur to Identify Biomarkers of Flu Vaccine Performance

Press releases

Showing 21 of 149 media posts - Page 3 of 8

Berg Media

BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

How Big Pharma is Using AI to Make Better Drugs

Chief Analytics Officer Slava Akmaev to Speak at BioData World

Assoc. Dir. of Advanced Analytics Leo Rodrigues to Discuss Industrialization of AI

Assoc. Dir. of Advanced Analytics Leo Rodrigues to Speak at AI in Pharma Summit

Chief Analytics Officer Slava Akmaev to Speak at SCOPE

AI is Helping Turn Tide Against Flu in Two Important Ways

BERG Announces FDA Orphan-Drug Designation of BPM31510 for the Treatment of Pancreatic Cancer

Flu Epidemic Could Cost Employers $9 Billion

Flu-pocalypse? Why Scientists are Scrambling to Make ‘Universal Influenza Vaccine’

Chief Analytics Officer Slava Akmaev to Speak at Precision Medicine World Conference

BERG Teams with Mass General Hospital, Brigham and Women’s Hospital to Combat Alzheimer’s Disease

New Research Partnership will Leverage BERG’s Interrogative Biology® Platform to Identify Novel Biomarker and Targets for Diagnosis and Treatment of Alzheimer’s Disease

Chief Analytics Officer Slava Akmaev to Speak at AI Applications Summit

BERG, AstraZeneca Partnership Highlighted in Forbes Column

BERG Helps Establish McLeod Research Fellowship at USUHS

BERG at Neuroscience 2017 Conference

CEO Niven Narain Discusses Partnership with Sanofi Pasteur

BERG, Sanofi team up on AI-flu vaccine project

Sanofi turns to artificial intelligence to beat flu

BERG Enters Into an Agreement With Sanofi Pasteur to Identify Biomarkers of Flu Vaccine Performance

BERG in the News!

BERG is making headlines. Click here to see the latest breaking news, interviews, and press releases.